Colgate Announces 1st Quarter 2026 Results
- Net sales increased 8.4%; Organic sales* increased 2.9%, including a 0.6% negative impact from lower private label pet food sales
-
GAAP EPS decreased 6% to
$0.80 ; Base Business EPS* increased 7% to$0.97 - GAAP Gross profit margin and Base Business Gross profit margin* decreased 20 basis points to 60.6%
-
Net cash provided by operations was
$747 million for the first three months of 2026 - The Company’s leadership in toothpaste continued with its global market share at 41.1% year to date
- The Company’s leadership in manual toothbrushes continued with its global market share at 32.6% year to date
- The Company maintained its sales and earnings per share guidance and updated its gross profit margin guidance for full year 2026
|
First Quarter Total Company Results (GAAP) |
|||
|
($ in millions except per share amounts) |
2026 |
2025 |
Change |
|
|
|
|
+8.4% |
|
EPS (diluted) |
|
|
-6% |
|
|
|
|
|
|
|
|
|
|
|
First Quarter Total Company Results (Base Business - Non-GAAP)* |
|||
|
|
2026 |
2025 |
Change |
|
Organic Sales Growth |
+2.9% |
||
|
Base Business EPS (diluted) |
|
|
+7% |
|
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” and “Table 6 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
"These results underscore the resilience of our business model as we are able to execute against our long-term strategy while delivering strong results in a difficult operating environment. While we expect the volatile macroeconomic conditions and slower category growth to continue in 2026, we are aligned behind our 2030 strategy to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.”
Separately, building on the Company’s successful implementation of the
Full Year 2026 Guidance
Based on current spot rates and including the estimated impact of tariffs announced and finalized as of
- The Company still expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.
- The Company still expects organic sales growth to be 1% to 4%. This includes the impact from our exit from the private label pet food business.
- On a GAAP basis, the Company now expects gross profit margin to be down (versus up previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.
- On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be down (versus up previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also still expects low to mid-single-digit earnings per share growth.
Divisional Performance
See attached "Table 5 - Geographic Sales Analysis Percentage Changes" and "Table 4 - Segment Information" for additional information on net sales and operating profit by division.
|
First Quarter Sales Growth By Division
|
|
|
||||
|
|
% of Total
|
Net
|
Organic
|
As
|
Pricing |
FX |
|
|
17% |
-1.8% |
-2.2% |
-3.2% |
+1.0% |
+0.4% |
|
|
25% |
+14.8% |
+5.4% |
+2.0% |
+3.4% |
+9.5% |
|
|
21% |
+11.9% |
+3.5% |
+2.2% |
+1.2% |
+8.5% |
|
|
15% |
+8.9% |
+5.6% |
+4.6% |
+1.0% |
+3.3% |
|
|
22% |
+6.7% |
+2.1% |
+0.2% |
+3.8% |
+2.7% |
|
|
|
|
|
|
|
|
|
|
100% |
+8.4% |
+2.9% |
+1.1% |
+2.2% |
+5.1% |
|
Note: Table may not sum due to rounding. |
|
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended |
|
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
|
**The impact of the acquisition of the Prime100 pet food business on as reported volume was 1.9% and 0.4% for Hill's |
|
First Quarter Operating Profit By Division ($ in millions) |
|
|||
|
|
1Q 2026 |
% Change vs
|
% to Net
|
Change in basis
|
|
|
|
-28% |
15.8% |
-590 |
|
|
|
15% |
30.6% |
+20 |
|
|
|
20% |
23.6% |
+160 |
|
|
|
9% |
27.6% |
-10 |
|
|
|
8% |
23.4% |
+30 |
|
|
|
|
|
|
|
|
|
-10% |
18.1% |
-380 |
|
|
|
4% |
21.3% |
-90 |
|
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended |
|
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
Prepared Materials and Webcast Information
At approximately
At
About
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. Except as otherwise noted, all market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from
Cautionary Statement on Forward-Looking Statements
This press release and the related prepared materials and webcast may contain forward-looking statements (as that term is defined in the
Non-GAAP Financial Measures
The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:
-
Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the
Strategic Growth and Productivity Program and the ERISA litigation matter. - Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
- Free cash flow before dividends: Net cash provided by operations less Capital expenditures.
This press release and the related prepared materials and webcast discuss Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three months ended
Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the three months ended
(See attached tables for first quarter results.)
|
|
|
|
|
Table 1 |
||||
|
|
||||||||
|
|
||||||||
|
Condensed Consolidated Statements of Income |
||||||||
|
|
||||||||
|
For the Three Months Ended |
||||||||
|
|
||||||||
|
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
||||||||
|
|
||||||||
|
|
|
2026 |
|
2025 |
||||
|
|
|
|
|
|
||||
|
Net sales |
|
$ |
5,324 |
|
|
$ |
4,911 |
|
|
|
|
|
|
|
||||
|
Cost of sales |
|
|
2,098 |
|
|
|
1,924 |
|
|
|
|
|
|
|
||||
|
Gross profit |
|
|
3,226 |
|
|
|
2,987 |
|
|
|
|
|
|
|
||||
|
Gross profit margin |
|
|
60.6 |
% |
|
|
60.8 |
% |
|
|
|
|
|
|
||||
|
Selling, general and administrative expenses |
|
|
2,076 |
|
|
|
1,898 |
|
|
|
|
|
|
|
||||
|
Other (income) expense, net |
|
|
186 |
|
|
|
13 |
|
|
|
|
|
|
|
||||
|
Operating profit |
|
|
964 |
|
|
|
1,076 |
|
|
|
|
|
|
|
||||
|
Operating profit margin |
|
|
18.1 |
% |
|
|
21.9 |
% |
|
|
|
|
|
|
||||
|
Non-service related postretirement costs |
|
|
26 |
|
|
|
72 |
|
|
|
|
|
|
|
||||
|
Interest expense |
|
|
62 |
|
|
|
66 |
|
|
|
|
|
|
|
||||
|
Interest income |
|
|
16 |
|
|
|
15 |
|
|
|
|
|
|
|
||||
|
Income before income taxes |
|
|
892 |
|
|
|
953 |
|
|
|
|
|
|
|
||||
|
Provision for income taxes |
|
|
211 |
|
|
|
227 |
|
|
|
|
|
|
|
||||
|
Effective tax rate |
|
|
23.6 |
% |
|
|
23.7 |
% |
|
|
|
|
|
|
||||
|
Net income including noncontrolling interests |
|
|
681 |
|
|
|
726 |
|
|
|
|
|
|
|
||||
|
Less: Net income attributable to noncontrolling interests |
|
|
35 |
|
|
|
36 |
|
|
|
|
|
|
|
||||
|
Net income attributable to |
|
$ |
646 |
|
|
$ |
690 |
|
|
|
|
|
|
|
||||
|
Earnings per common share |
|
|
|
|
||||
|
Basic |
|
$ |
0.81 |
|
|
$ |
0.85 |
|
|
Diluted |
|
$ |
0.80 |
|
|
$ |
0.85 |
|
|
|
|
|
|
|
||||
|
Supplemental Income Statement Information |
|
|
|
|
||||
|
Average common shares outstanding |
|
|
|
|
||||
|
Basic |
|
|
802.3 |
|
|
|
812.0 |
|
|
Diluted |
|
|
805.1 |
|
|
|
815.0 |
|
|
|
|
|
|
|
||||
|
Advertising |
|
$ |
734 |
|
|
$ |
668 |
|
|
|
|
|
|
|
|
Table 2 |
||||||
|
|
||||||||||||
|
|
||||||||||||
|
Condensed Consolidated Balance Sheets |
||||||||||||
|
|
||||||||||||
|
As of |
||||||||||||
|
|
||||||||||||
|
(Dollars in Millions) (Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
2026 |
|
2025 |
|
2025 |
||||||
|
Cash and cash equivalents |
|
$ |
1,335 |
|
|
$ |
1,288 |
|
|
$ |
1,112 |
|
|
Receivables, net |
|
|
1,889 |
|
|
|
1,675 |
|
|
|
1,725 |
|
|
Inventories |
|
|
2,086 |
|
|
|
2,032 |
|
|
|
2,125 |
|
|
Other current assets |
|
|
772 |
|
|
|
714 |
|
|
|
852 |
|
|
Property, plant and equipment, net |
|
|
4,622 |
|
|
|
4,660 |
|
|
|
4,416 |
|
|
|
|
|
3,107 |
|
|
|
3,122 |
|
|
|
3,334 |
|
|
Other intangible assets, net |
|
|
1,521 |
|
|
|
1,536 |
|
|
|
1,782 |
|
|
Other assets |
|
|
1,278 |
|
|
|
1,303 |
|
|
|
1,301 |
|
|
Total assets |
|
$ |
16,610 |
|
|
$ |
16,330 |
|
|
$ |
16,647 |
|
|
|
|
|
|
|
|
|
||||||
|
Total debt |
|
$ |
7,973 |
|
|
$ |
7,988 |
|
|
$ |
8,269 |
|
|
Other current liabilities |
|
|
5,898 |
|
|
|
5,736 |
|
|
|
5,163 |
|
|
Other non-current liabilities |
|
|
2,253 |
|
|
|
2,241 |
|
|
|
2,482 |
|
|
Total liabilities |
|
|
16,124 |
|
|
|
15,965 |
|
|
|
15,914 |
|
|
|
|
|
145 |
|
|
|
54 |
|
|
|
363 |
|
|
Noncontrolling interests |
|
|
341 |
|
|
|
311 |
|
|
|
370 |
|
|
Total liabilities and equity |
|
$ |
16,610 |
|
|
$ |
16,330 |
|
|
$ |
16,647 |
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental Balance Sheet Information |
|
|
|
|
|
|
||||||
|
Debt less cash, cash equivalents and marketable securities(1) |
|
$ |
6,554 |
|
|
$ |
6,593 |
|
|
$ |
6,958 |
|
|
Working capital % of sales |
|
|
(5.7 |
)% |
|
|
(7.0 |
)% |
|
|
(3.3 |
)% |
|
Note: |
|
(1) Marketable securities of |
|
|
|
|
|
Table 3 |
||||
|
|
||||||||
|
|
||||||||
|
Condensed Consolidated Statements of Cash Flows |
||||||||
|
|
||||||||
|
For the Three Months Ended |
||||||||
|
|
||||||||
|
(Dollars in Millions) (Unaudited) |
||||||||
|
|
|
|
|
|
||||
|
|
|
2026 |
|
2025 |
||||
|
Operating Activities |
|
|
|
|
||||
|
Net income including noncontrolling interests |
|
$ |
681 |
|
|
$ |
726 |
|
|
Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations: |
|
|
||||||
|
Depreciation and amortization |
|
|
156 |
|
|
|
148 |
|
|
ERISA litigation matter |
|
|
— |
|
|
|
65 |
|
|
Restructuring and termination benefits, net of cash |
|
|
165 |
|
|
|
(7 |
) |
|
Stock-based compensation expense |
|
|
40 |
|
|
|
23 |
|
|
Deferred income taxes |
|
|
(18 |
) |
|
|
(24 |
) |
|
Cash effects of changes in: |
|
|
|
|
||||
|
Receivables |
|
|
(215 |
) |
|
|
(174 |
) |
|
Inventories |
|
|
(41 |
) |
|
|
(86 |
) |
|
Accounts payable and other working capital |
|
|
(11 |
) |
|
|
(57 |
) |
|
Other non-current assets |
|
|
19 |
|
|
|
(1 |
) |
|
Other non-current liabilities |
|
|
(29 |
) |
|
|
(13 |
) |
|
Net cash provided by (used in) operations |
|
|
747 |
|
|
|
600 |
|
|
|
|
|
|
|
||||
|
Investing Activities |
|
|
|
|
||||
|
Capital expenditures |
|
|
(138 |
) |
|
|
(124 |
) |
|
Purchases of marketable securities and investments |
|
|
(70 |
) |
|
|
(134 |
) |
|
Proceeds from sale of marketable securities and investments |
|
|
94 |
|
|
|
97 |
|
|
Other investing activities |
|
|
(8 |
) |
|
|
2 |
|
|
Net cash provided by (used in) investing activities |
|
|
(122 |
) |
|
|
(159 |
) |
|
|
|
|
|
|
||||
|
Financing Activities |
|
|
|
|
||||
|
Short-term borrowing (repayment) less than 90 days, net |
|
|
1,138 |
|
|
|
164 |
|
|
Principal payments on debt |
|
|
(1,082 |
) |
|
|
(4 |
) |
|
Proceeds from issuance of debt |
|
|
— |
|
|
|
— |
|
|
Dividends paid |
|
|
(417 |
) |
|
|
(406 |
) |
|
Purchases of treasury shares |
|
|
(306 |
) |
|
|
(284 |
) |
|
Proceeds from exercise of stock options |
|
|
127 |
|
|
|
40 |
|
|
Other financing activities |
|
|
(23 |
) |
|
|
32 |
|
|
Net cash provided by (used in) financing activities |
|
|
(563 |
) |
|
|
(458 |
) |
|
|
|
|
|
|
||||
|
Effect of exchange rate changes on Cash and cash equivalents |
|
|
(15 |
) |
|
|
33 |
|
|
Net increase (decrease) in Cash and cash equivalents |
|
|
47 |
|
|
|
16 |
|
|
Cash and cash equivalents at beginning of the period |
|
|
1,288 |
|
|
|
1,096 |
|
|
Cash and cash equivalents at end of the period |
|
$ |
1,335 |
|
|
$ |
1,112 |
|
|
|
|
|
|
|
||||
|
Supplemental Cash Flow Information |
|
|
|
|
||||
|
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) |
|
|
|
|
||||
|
Net cash provided by operations |
|
$ |
747 |
|
|
$ |
600 |
|
|
Less: Capital expenditures |
|
|
(138 |
) |
|
|
(124 |
) |
|
Free cash flow before dividends |
|
$ |
609 |
|
|
$ |
476 |
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
Income taxes paid |
|
$ |
176 |
|
|
$ |
139 |
|
|
Interest paid |
|
$ |
96 |
|
|
$ |
109 |
|
|
|
|
|
|
Table 4 |
||||
|
|
||||||||
|
|
||||||||
|
Segment Information |
||||||||
|
|
||||||||
|
For the Three Months Ended |
||||||||
|
|
||||||||
|
(Dollars in Millions) (Unaudited) |
||||||||
|
|
|
|
||||||
|
|
|
Three Months Ended |
||||||
|
|
|
2026 |
|
2025 |
||||
|
|
|
|
|
|
||||
|
Oral, Personal and Home Care |
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
$ |
888 |
|
|
$ |
904 |
|
|
|
|
|
1,313 |
|
|
|
1,143 |
|
|
|
|
|
1,126 |
|
|
|
1,007 |
|
|
|
|
|
804 |
|
|
|
738 |
|
|
|
|
|
|
|
||||
|
Total Oral, Personal and Home Care |
|
|
4,131 |
|
|
|
3,792 |
|
|
|
|
|
|
|
||||
|
Pet Nutrition |
|
|
1,194 |
|
|
|
1,118 |
|
|
|
|
|
|
|
||||
|
Total |
|
$ |
5,324 |
|
|
$ |
4,911 |
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
Three Months Ended |
||||||
|
|
|
2026 |
|
2025 |
||||
|
Operating Profit |
|
|
|
|
||||
|
Oral, Personal and Home Care |
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
$ |
141 |
|
|
$ |
197 |
|
|
|
|
|
401 |
|
|
|
348 |
|
|
|
|
|
266 |
|
|
|
222 |
|
|
|
|
|
222 |
|
|
|
204 |
|
|
|
|
|
|
|
||||
|
Total Oral, Personal and Home Care |
|
|
1,030 |
|
|
|
971 |
|
|
|
|
|
|
|
||||
|
Pet Nutrition |
|
|
280 |
|
|
|
258 |
|
|
Corporate(2) |
|
|
(346 |
) |
|
|
(153 |
) |
|
|
|
|
|
|
||||
|
Total Operating Profit |
|
$ |
964 |
|
|
$ |
1,076 |
|
|
Tables may not sum due to rounding. |
|
|
|
Notes: |
|
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended |
|
(2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. |
|
|
|
Corporate Operating profit (loss) for the three months ended |
|
|
|
Corporate Operating profit (loss) for the three months ended |
|
Table 5 |
||||||||||||||||||
|
|
||||||||||||||||||
|
|
||||||||||||||||||
|
Geographic Sales Analysis Percentage Changes |
||||||||||||||||||
|
|
||||||||||||||||||
|
For the Three Months Ended |
||||||||||||||||||
|
|
||||||||||||||||||
|
(Unaudited) |
||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Pricing |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
Coupons |
|
|
||||||
|
|
|
Sales |
|
|
|
|
|
|
|
Consumer & |
|
|
||||||
|
|
|
Change |
|
Organic |
|
As Reported |
|
Organic |
|
Trade |
|
Foreign |
||||||
|
Region |
|
As Reported |
|
Sales Change |
|
Volume(1) |
|
Volume |
|
Incentives |
|
Exchange |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
8.4 |
% |
|
2.9 |
% |
|
1.1 |
% |
|
0.6 |
% |
|
2.2 |
% |
|
5.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
(1.8 |
)% |
|
(2.2 |
)% |
|
(3.2 |
)% |
|
(3.2 |
)% |
|
1.0 |
% |
|
0.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
14.8 |
% |
|
5.4 |
% |
|
2.0 |
% |
|
2.0 |
% |
|
3.4 |
% |
|
9.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
11.9 |
% |
|
3.5 |
% |
|
2.2 |
% |
|
2.2 |
% |
|
1.2 |
% |
|
8.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
8.9 |
% |
|
5.6 |
% |
|
4.6 |
% |
|
4.6 |
% |
|
1.0 |
% |
|
3.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Total CP Products |
|
8.9 |
% |
|
3.1 |
% |
|
1.3 |
% |
|
1.3 |
% |
|
1.8 |
% |
|
5.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Hill’s Pet Nutrition |
|
6.7 |
% |
|
2.1 |
% |
|
0.2 |
% |
|
(1.7 |
)% |
|
3.8 |
% |
|
2.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Emerging Markets(3) |
|
12.9 |
% |
|
6.2 |
% |
|
3.5 |
% |
|
3.5 |
% |
|
2.7 |
% |
|
6.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Developed Markets |
|
4.9 |
% |
|
0.2 |
% |
|
(0.9 |
)% |
|
(1.7 |
)% |
|
1.9 |
% |
|
3.9 |
% |
|
Table may not sum due to rounding. |
|
|
|
Notes: |
|
(1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.4%, 1.9% and 0.8% for |
|
(2) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended |
|
(3) Emerging Markets include |
|
Table 6 |
|||||||||||
|
|
|||||||||||
|
|
|||||||||||
|
Non-GAAP Reconciliations |
|||||||||||
|
|
|||||||||||
|
For the Three Months Ended |
|||||||||||
|
|
|||||||||||
|
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
|||||||||||
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|||||
|
Selling, General and Administrative Expenses |
2026 |
|
2025 |
|
|
||||||
|
Selling, general and administrative expenses, GAAP |
$ |
2,076 |
|
|
$ |
1,898 |
|
|
|
||
|
|
|
(6 |
) |
|
|
— |
|
|
|
||
|
ERISA litigation matter |
|
— |
|
|
|
(15 |
) |
|
|
||
|
Selling, general and administrative expenses, non-GAAP |
$ |
2,071 |
|
|
$ |
1,883 |
|
|
|
||
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|||||
|
Selling, General and Administrative Expenses as a Percentage of |
2026 |
|
2025 |
|
Change |
||||||
|
Selling, general and administrative expenses as a percentage of Net sales, GAAP |
|
39.0 |
% |
|
|
38.6 |
% |
|
40 |
|
|
|
|
|
(0.1 |
)% |
|
|
— |
% |
|
|
||
|
ERISA litigation matter |
|
— |
% |
|
|
(0.3 |
)% |
|
|
||
|
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP |
|
38.9 |
% |
|
|
38.3 |
% |
|
60 |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|||||
|
Other (Income) Expense, Net |
2026 |
|
2025 |
|
|
||||||
|
Other (income) expense, net, GAAP |
$ |
186 |
|
|
$ |
13 |
|
|
|
||
|
|
|
(165 |
) |
|
|
— |
|
|
|
||
|
Other (income) expense, net, non-GAAP |
$ |
21 |
|
|
$ |
13 |
|
|
|
||
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|||||
|
Operating Profit |
|
2026 |
|
2025 |
|
% Change |
|||||
|
Operating profit, GAAP |
|
$ |
964 |
|
|
$ |
1,076 |
|
|
(10 |
)% |
|
|
|
171 |
|
|
|
— |
|
|
|
||
|
ERISA litigation matter |
|
|
— |
|
|
|
15 |
|
|
|
|
|
Operating profit, non-GAAP |
|
$ |
1,134 |
|
|
$ |
1,091 |
|
|
4 |
% |
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|||||
|
Operating Profit Margin |
2026 |
|
2025 |
|
Change |
||||||
|
Operating profit margin, GAAP |
|
18.1 |
% |
|
|
21.9 |
% |
|
(380 |
) |
|
|
|
|
3.2 |
% |
|
|
— |
% |
|
|
||
|
ERISA litigation matter |
|
|
— |
% |
|
|
0.3 |
% |
|
|
|
|
Operating profit margin, non-GAAP |
|
21.3 |
% |
|
|
22.2 |
% |
|
(90 |
) |
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||
|
Non-Service Related Postretirement Costs |
2026 |
|
2025 |
|
|
||||||
|
Non-service related postretirement costs, GAAP |
$ |
26 |
|
|
$ |
72 |
|
|
|
||
|
|
|
(5 |
) |
|
|
— |
|
|
|
||
|
ERISA litigation matter |
|
|
— |
|
|
|
(50 |
) |
|
|
|
|
Non-service related postretirement costs, non-GAAP |
$ |
20 |
|
|
$ |
22 |
|
|
|
||
|
|
|
|
|
|
|
|
|||||
|
Note: The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |
|
Table 6 |
||||||||||||||||||||||
|
Continued |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
Non-GAAP Reconciliations |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
For the Three Months Ended |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
2026 |
|||||||||||||||||||||
|
|
Income
|
|
Provision
|
|
Net Income
|
|
Less: Income
|
|
Net Income
|
|
Effective
|
|
Diluted
|
|||||||||
|
As Reported GAAP |
$ |
892 |
|
$ |
211 |
|
$ |
681 |
|
$ |
35 |
|
$ |
646 |
|
23.6 |
% |
|
$ |
0.80 |
||
|
|
|
176 |
|
|
37 |
|
|
139 |
|
|
1 |
|
|
138 |
|
(0.4 |
)% |
|
|
0.17 |
||
|
Non-GAAP |
$ |
1,068 |
|
$ |
248 |
|
$ |
820 |
|
$ |
36 |
|
$ |
784 |
|
23.2 |
% |
|
$ |
0.97 |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
2025 |
|||||||||||||||||||||
|
|
Income
|
|
Provision
|
|
Net Income
|
|
Less: Income
|
|
Net Income
|
|
Effective
|
|
Diluted
|
|||||||||
|
As Reported GAAP |
$ |
953 |
|
$ |
227 |
|
$ |
726 |
|
$ |
36 |
|
$ |
690 |
|
23.7 |
% |
|
$ |
0.85 |
||
|
ERISA litigation matter |
|
65 |
|
|
12 |
|
|
53 |
|
|
— |
|
|
53 |
|
(0.3 |
)% |
|
|
0.06 |
||
|
Non-GAAP |
$ |
1,018 |
|
$ |
239 |
|
$ |
779 |
|
$ |
36 |
|
$ |
743 |
|
23.4 |
% |
|
$ |
0.91 |
||
|
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |
|
|
|
Notes: |
|
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
|
|
|
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260501892320/en/
Investor Relations: investor_relations@colpal.com
Communications: colgate_palmolive_media_inquiry@colpal.com
Source: